Hartig Drug Co Corp

Community/Retail Pharmacy



  
  180 W Pine St, Platteville
Wisconsin, 53818-3112

 608-348-9771    608-348-4340
Hartig Drug Co Corp is a Community/Retail Pharmacy in Platteville, Wisconsin. It is located at 180 W Pine St, Platteville and it's customer support contact number is 608-348-9771. The authorized person of Hartig Drug Co Corp is Charles S Hartig, PHARMD, JD who is Ceo of the pharmacy and his contact number is 563-588-8700. Hartig Drug Co Corp accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Hartig Drug Co Corp is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.


Pharmacy Details:
Hartig Drug Co Corp type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name: Hartig Drug Co Corp
Type: Community/Retail Pharmacy
Location:180 W Pine St, Platteville,
Wisconsin, 53818-3112
Phone:608-348-9771
Fax:608-348-4340
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name: Charles S Hartig
Credentials: PHARMD, JD
Position: Ceo
Contact Number: 563-588-8700
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number: 1053418624
NPI Enumeration Date: 17 Sep, 2006
NPI Last Update On: 05 Aug, 2021

Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Hartig Drug Co Corp are as mentioned below.
SpecializationLicense NumberStateStatus
Community/Retail Pharmacy Primary
Community/Retail Pharmacy 8297-042WisconsinSecondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
IdentifierTypeStateIssuer
33268300MedicaidWisconsin
Medicare Enrollment:
Hartig Drug Co Corp is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID: Enrollment ID: Org NameMedicare Entity Type
2365434412O20100930093400Hartig Drug Co CorpDME SUPPLIER - PHARMACY
Products Available:
Hartig Drug Co Corp has following products available for sale under medicare.
Products:
•  Blood Glucose Monitors & Supplies: Non-mail Order•  Canes & Crutches
•  Commodes, Urinals, & Bedpans•  Enteral Nutrients
•  Infusion Pumps & Supplies: Insulin Infusion•  Nebulizer Equipment & Supplies
•  Orthoses: Off-the-shelf•  Ostomy Supplies
•  Surgical Dressings•  Walkers
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 703 Main St,
Dubuque, Iowa
Zip: 52001-6821
Phone Number: 563-588-8700
Fax Number: 563-588-8750
Patients can reach Hartig Drug Co Corp at 180 W Pine St, Platteville, Wisconsin or can call on customer care at 608-348-9771.
Comments/ Reviews:
Read all the reviews posted for Hartig Drug Co Corp below. You may also share your own experience with Hartig Drug Co Corp. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.